The European survey on adverse systemic reactions due to allergen immunotherapy: study doctors' and patients' inclusion criteria

被引：0
|
作者：
Rodriguez del Rio, P. [1 ]
Vidal, C. [2 ]
Just, J. [3 ]
Pfaar, O. [4 ]
Passalacqua, G. [5 ]
Demoly, P. [6 ]
Calderon, M. A. [7 ]
机构：
[1] Hosp Univ Nino Jesus, Madrid, Spain
[2] Hosp Clin Univ, Santiago De Compostela, Spain
[3] Hop Enfant Armand Trousseau, Ctr Asthme & Allergies, Paris, France
[4] Univ HNO Klin Mannheim, Zentrum Rhinol & Allergol, Wiesbaden, Germany
[5] Univ Genoa, Genoa, Italy
[6] Univ Hosp Montpellier, Hop Arnaud Villeneuve, Clin Malad Resp, Montpellier, France
[7] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England
来源：
ALLERGY | 2013年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：477 / 477
页数：1
相关论文
共 50 条
  • [21] Characteristics of adverse reactions due to subcutaneous allergen immunotherapy applied between 2011-2021: Single center experience
    Solak, Gurgun Tugce Vural
    Aksu, Kurtulus
    Solak, Yavuzalp
    Demir, Senay
    Ercelebi, Dilek Cuhadar
    Buhari, Gozde Koycu
    Bahcecioglu, Sakine Nazik
    Kalkan, Ilkay Koca
    Ates, Hale
    Yesilkaya, Selma
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2023, 71 (04): : 356 - 366
  • [22] Effectiveness of sublingual allergen-specific immunotherapy (ASIT) in patients with adverse gastrointestinal reactions in the course of the therapy
    Peredelskaya, M.
    Nenasheva, N.
    ALLERGY, 2019, 74 : 641 - 641
  • [23] Pollen season as a risk factor for systemic reactions due to allergen immunotherapy. Results of a 10 years long, real life, prospective study
    Pitsios, C.
    Dimitriou, A.
    Lefousis, C.
    Giannakopoulos, D.
    Kouri, M.
    Ergazakis, M.
    Vartholomaios, S.
    ALLERGY, 2015, 70 : 260 - 261
  • [24] RISK OF SYSTEMIC REACTIONS IN PATIENTS TAKING BETA-BLOCKER DRUGS RECEIVING ALLERGEN IMMUNOTHERAPY INJECTIONS
    HEPNER, MJ
    OWNBY, DR
    ANDERSON, JA
    ROWE, MS
    SEARSEWALD, D
    BROWN, EB
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1990, 86 (03) : 407 - 411
  • [25] Systemic Reactions in Pediatric Patients Receiving Standardized Allergen Subcutaneous Immunotherapy with and without Seasonal Dose Adjustment
    Albuhairi, Sultan
    Sare, Tatyana
    Lakin, Paul
    El Khoury, Kristel
    Crestani, Elena
    Schneider, Lynda C.
    Anzaldi, Rocco
    Patterson, Al
    Rachid, Rima
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (05): : 1711 - +
  • [26] Systemic Reactions (SR) and Anaphylaxis Associated with Subcutaneous Allergen Immunotherapy (AIT): A National Annual Surveillance Study
    Bernstein, D. I.
    Murphy, K.
    Liss, G. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (03) : 727 - 727
  • [27] Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy
    Bernstein, David, I
    Epstein, Tolly E. G.
    ALLERGY AND ASTHMA PROCEEDINGS, 2020, 41 (02) : 108 - 111
  • [28] Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study
    Asero, R.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 47 (06) : 211 - 217
  • [29] A Preliminary Review of Systemic Reactions Due to Subcutaneous Allergen Immunotherapy (SCIT) from the Allergy Partners Organization (2019-2020)
    Taha, Omar
    Atalla, Jasmyn
    Taha, Yousef
    Carolan, Christopher
    McCann, William
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB5 - AB5
  • [30] Release of mediators in patients with systemic anaphylactic reactions (SAR) due to immunotherapy (IT) with bee venom.
    Gniazdowska, B
    EberleinKonig, B
    Przybilla, B
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 608 - 608
12345